TECENTRIQ subkutan 1875 mg/15ml
TECENTRIQ subkutan 1875 mg/15ml is a medicine authorised by Swissmedic under authorisation number 69262. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 05 August 2024 and the authorisation is limited until 04 August 2029. ATC code L01FF05 places the medicine in the group Antineoplastic agents.
| Authorisation number | 69262 |
|---|---|
| Name | TECENTRIQ subkutan 1875 mg/15ml |
| Full name | TECENTRIQ subkutan 1875 mg/15ml, Injektionslösung zur subkutanen Anwendung |
| Authorisation holder | Roche Pharma (Schweiz) AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FF05 |
| First authorisation | 05 August 2024 |
| Authorisation validity | 04 August 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | TECENTRIQ subkutan 1875 mg/15ml, Injektionslösung zur subkutanen Anwendung | A | 05 August 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FF05 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is TECENTRIQ subkutan 1875 mg/15ml authorised in Switzerland?
Yes. TECENTRIQ subkutan 1875 mg/15ml is authorised by Swissmedic under authorisation number 69262, data as of 01 September 2026. The authorisation is limited until 04 August 2029.
Which dispensing category does TECENTRIQ subkutan 1875 mg/15ml have?
TECENTRIQ subkutan 1875 mg/15ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of TECENTRIQ subkutan 1875 mg/15ml?
The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.